Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

CHDI Foundation presents novel HDAC4 inhibitors

Aug. 20, 2012

Novel complement activation-inhibiting products synthesized

Aug. 17, 2012

New candidate immunotherapies divulged by UCB

Aug. 17, 2012

Investigation yields novel candidate anticancer drugs

Aug. 17, 2012

New potential candidate cognition-enhancing drugs designed

Aug. 17, 2012

Boehringer Ingelheim Pharma patents new prostanoid DP2 receptor antagonists

Aug. 17, 2012

Roche reports novel bradykinin B1 receptor antagonists

Aug. 17, 2012

GSK develops new RAR-related orphan receptor-gamma modulators

Aug. 17, 2012

New candidate analgesics synthesized at Eli Lilly

Aug. 16, 2012

Curegenix reports new lysophospholipid LPA1 receptor antagonists

Aug. 16, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...